Sunlogics Power Fund Management Inc. (SLMU)   

Sunlogics Power Fund Management Inc., is a solar energy project funder specializing in ECO friendly green power projects. It has the exclusive first right of refusal as the project funding partner of Sunlogics Inc., a vertically integrated solar energy company. Sunlogics Power Fund Management Inc. is focused on the acquisition of solar powered electricity generating facilities which have long term power purchasing agreements in place with local power utilities. Sunlogics has existing business relationships with General Motors, International Power, Energizer, and many other large entities.

http://www.sunlogics.com

MEDICAL CARE TECHNOLOGIES INC.

http://www.medicaretechinc.com/

We are engaged principally in the business of opening and operating private health and wellness clinics for children in China

Our planned products and/services also constitute a healthcare delivery and wellness site; dedicated to helping Chinese consumers live healthier, more balanced lives.

MDCE Security Details

Share Structure
Market Value- $2,424,371 a/o Apr 21, 2011
Shares Outstanding- 164,923,228 a/o Mar 31, 2011
Float -Not Available
Authorized Shares- 500,000,000 a/o Sep 17, 2010
Par Value 0.00001

Marquis Tech Holdings is currently in the process of building a successful portfolio of technology and real estate assets. In our role as managers, operators, and marketers of technologies we believe that leveraging our industry experience and capitalizing on our strategic relationships are the best ways to achieve profitable results.

Marquis Tech Holdings’ company philosophy is to acquire domestic and international companies which possess an inherent competitive edge whether it’s derived through written law, intellectual property, or government contracts and inject the capital necessary to maximize earnings while pooling resources and managing the logistics to ensure all acquisitions operate in efficient harmony.

Nanosphere, Inc. is engaged in developing, manufacturing and marketing a molecular diagnostics platform, the Verigene System, that enables genomic and protein testing on a single platform. The Company’s nanoparticle technology simplifies molecular diagnostic testing, provides the ability to run multiple tests simultaneously on the same sample and has the potential to run a menu of tests on a single platform. The Company is developing diagnostic tests for markers, which reveal the existence of a range of medical conditions including cardiovascular, respiratory, cancer, autoimmune, neurodegenerative and other infectious diseases, as well as for pharmacogenomics.